29th Annual North American Cystic Fibrosis Conference

Oct 7, 2015 ‐ Oct 10, 2015



The synchronized sessions from the 2015 NACFC are NOW AVAILABLE!

Full NACFC registrants have complimentary access to the recordings of the 2015 NACFC Plenary sessions, Symposia and Workshops.

Short Course presentations held on Wednesday, October 7, are also available for an additional fee. To purchase access to the Short Course presentations, click here.


Sessions

S11: INF/MIC: MRSA UpdateS11: INF/MIC: MRSA Update

Preview Available

S11: INF/MIC: MRSA Update

Oct 9, 2015 10:30am ‐ Oct 9, 2015 12:20pm

This session will provide an update on MRSA infection in CF patients.

Educational Objectives:

  1. Review the most recent findings regarding the epidemiology & outcomes associated with MRSA infection in CF patients.
  2. Describe current studies designed to eradicate MRSA infection in CF patients.
  3. Summarize the current & emerging therapies for MRSA infection in CF patients.

Speaker(s):
Standard: $49.99

*** S12: CLIN: CF With Fresh Eyes: A Partnership to Create the Future?

Oct 9, 2015 10:30am ‐ Oct 9, 2015 12:20pm

This symposium will explore some of the implications of co-production in the world of CF. Patients, family & professionals will work together to offer an introduction to the idea & to begin the process of seeing its relevance in the daily work life of all involved in designing the future of CF healthcare services.

Educational Objectives: 

  1. Demonstrate that knowledgeable, skillful patients & professionals working together are essential for better outcomes in CF.
  2. Recall that fear of new ways to collaborate must be replaced with exploration & discovery of new ways to work together.
  3. Discuss the appreciation of the role that language plays in framing our personal understanding & action-taking.
*** This session was streamed live during the 2015 NACFC. To watch free archived versions of the live streamed sessions, register here: https://arc.nacfconference.org/cff/live/14 

Speaker(s):
Standard: $49.99

*** S13: NRS: When Addiction Takes Over: Managing Dependence Issues in the Patient With CF

Oct 9, 2015 10:30am ‐ Oct 9, 2015 12:20pm

This symposium will provide insight into the multidisciplinary & multifaceted levels of care that are necessary to provide health support for the patient with CF while concurrently managing the challenges of a substance use disorder.

Educational Objectives: 

  1. List generally accepted, inappropriate & controversial indications for opioid prescription for painful conditions in CF.  
  2. Distinguish between opioid misuse, abuse, addiction & pseudoaddiction in patients with CF. 
  3. Discuss the complexity of addictive medication management in patients with CF, including skills to address existing concerns & prevent substance use problems.  
*** This session was streamed live during the 2015 NACFC. To watch free archived versions of the live streamed sessions, register here: https://arc.nacfconference.org/cff/live/14 

Speaker(s):
Standard: $49.99

*** S14: NTR: Achieving Optimal Nutrition

Oct 9, 2015 10:30am ‐ Oct 9, 2015 12:20pm

This session will review current knowledge related to DHA, linoleic acid & fatty acid metabolism in CF. We will also discuss emerging data on early nutrition & growth in infants with CF.

Educational Objectives: 

  1. Describe & discuss the concepts & controversies of LA supplementation in CF.  
  2. Describe & discuss the concepts & controversies of DHA supplementation in CF.
  3. Compare & contrast preliminary results & findings in optimizing infant growth & nutrition from an ongoing study & a recently concluded study of infants with CF.   
*** This session was streamed live during the 2015 NACFC. To watch free archived versions of the live streamed sessions, register here: https://arc.nacfconference.org/cff/live/14 

Speaker(s):
Standard: $49.99

*** BB05: PT & RT: Exercise Testing Interpretation & Implementing an Exercise Prescription

Oct 9, 2015 12:30pm ‐ Oct 9, 2015 1:50pm

Exercise capacity has been shown to predict patient outcomes, independent of lung function. Routine exercise testing is recommended, not only to evaluate exercise tolerance but to obtain the most effective exercise prescription for each individual patient. This session will expose you to the ins & outs of conducting an exercise test along with what & how to use the data.

Educational Objectives:

  1. Recall the essential monitoring requirements that are needed to conduct maximal exercise testing in patients with CF.
  2. Identify further insight into the comprehensive information that can be obtained from a maximal exercise test in patients with CF.
  3. Describe how maximal exercise testing can be used in a clinical setting to prescribe exercise to patients with CF.   
*** This session was streamed live during the 2015 NACFC. To watch free archived versions of the live streamed sessions, register here: https://arc.nacfconference.org/cff/live/14 

Speaker(s):
Standard: $49.99

W11: CFTR: Novel Insights Into CFTR 2015

Oct 9, 2015 2:00pm ‐ Oct 9, 2015 3:45pm

This session deals with fundamental questions central to our understanding of how the CFTR protein is structured & functions as an anion channel. There are also presentations related to the molecular basis for disease cause by mutations in CFTR & therapeutic strategies to repair such defects.

Educational Objectives:

  1. Discuss the current understanding regarding structure function relationships in CFTR.
  2. Explain molecular defects caused by mutation.
  3. Describe the mechanism of action of emerging interventions targeting defects caused by CFTR mutations.

Speaker(s):
Standard: $49.99

W12: APP&D: Mobilizing CF Mucus

Oct 9, 2015 2:00pm ‐ Oct 9, 2015 3:45pm

This session will provide a state-of-the art assessment of factors affecting mucus viscoelasticity & mucus clearance in in vitro & in vivo models of CF. These presentations will focus on the relationship between defective ion transport, fluid secretion & mucus biophysical properties, as well as methods for evaluating mucus transport & potentially normalizing mucus in a CF environment.

Educational Objectives:

  1. Explain effects of ion composition on biophysical properties of mucus.
  2. Describe CF & normal mucus secretion and transport.
  3. Identify pharmacological strategies to promote mucus clearance.

Speaker(s):
Standard: $49.99

W13: GMS: Genetics, Genomics & Big Data Sets

Oct 9, 2015 2:00pm ‐ Oct 9, 2015 3:45pm

During this session, we will explore the role of DNA & mRNA variation in CFTR mutations as well as the role of non-CFTR genetic modifiers in the phenotypic expression of disease.

Educational Objectives:

  1. Describe the contributions of CFTR variation in phenotypic manifestations of disease.
  2. Analyze how differential expression of CFTR mutations affects the potential for therapeutic targets.
  3. Discuss the potential role of non-CFTR genetic modifiers in the phenotypic expression of disease.

Speaker(s):
Standard: $49.99

W14: NT: Early Studies of Novel Small Molecule Therapies

Oct 9, 2015 2:00pm ‐ Oct 9, 2015 3:45pm

This session will consider novel small molecule therapeutic approaches directed at CF relevant drug targets, including delF508-CFTR, epithelial sodium channels & less frequent CFTR mutations. The session provides perspectives from academic & industrial laboratories.

Educational Objectives:

  1. Discuss innovative approaches to restore the expression, stability & function of delF508-CFTR.
  2. Review the challenges of developing rational new therapies for rare CF mutations.
  3. Explain the therapeutic potential for CF lung disease of small molecules that modify ENaC function.

Speaker(s):
Standard: $49.99

W15: INF/MIC: Microbiome & Emerging Pathogens

Oct 9, 2015 2:00pm ‐ Oct 9, 2015 3:45pm

The dynamic interactions of the microbial populations in the airway of CF patients can drive short & long term health. Newer technologies & bioinformatic approaches provide a comprehensive characterization & demonstrate interactions in unprecedented detail. This workshop highlights the CF microbiome, emerging pathogens & their impact on the health of CF patients.

Educational Objectives:

  1. Describe new technologies & bioinformatic approaches that allow the comprehensive analysis of the CF microbiome.
  2. Identify known & emerging pathogens in CF patients & how they might interact with other microbial pathogens to drive CF patient health.
  3. Discuss genomic & phenotypic adaptations of the microbial communities to survive in the CF airway.

Speaker(s):
Standard: $49.99
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content